Orient Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Orient Pharma has a total shareholder equity of NT$1.8B and total debt of NT$438.2M, which brings its debt-to-equity ratio to 24.7%. Its total assets and total liabilities are NT$2.6B and NT$831.4M respectively. Orient Pharma's EBIT is NT$144.0M making its interest coverage ratio 12.8. It has cash and short-term investments of NT$180.5M.
Key information
24.7%
Debt to equity ratio
NT$438.17m
Debt
| Interest coverage ratio | 12.8x |
| Cash | NT$180.54m |
| Equity | NT$1.77b |
| Total liabilities | NT$831.38m |
| Total assets | NT$2.60b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4166's short term assets (NT$739.0M) exceed its short term liabilities (NT$560.5M).
Long Term Liabilities: 4166's short term assets (NT$739.0M) exceed its long term liabilities (NT$270.9M).
Debt to Equity History and Analysis
Debt Level: 4166's net debt to equity ratio (14.5%) is considered satisfactory.
Reducing Debt: 4166's debt to equity ratio has increased from 16.9% to 24.7% over the past 5 years.
Debt Coverage: 4166's debt is well covered by operating cash flow (39%).
Interest Coverage: 4166's interest payments on its debt are well covered by EBIT (12.8x coverage).